HEPLISAV-B
Total Payments
$281,507
Transactions
44
Doctors
14
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $281,507 | 44 | 14 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $156,767 | 1 | 55.7% |
| Consulting Fee | $116,268 | 23 | 41.3% |
| Travel and Lodging | $7,850 | 9 | 2.8% |
| Food and Beverage | $621.95 | 11 | 0.2% |
Top Doctors Receiving Payments for HEPLISAV-B
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Rheumatology | La Jolla, CA | $180,648 | 9 |
| Carol Brosgart | — | Berkeley, CA | $77,977 | 17 |
| , MD | Clinical & Laboratory Immunology | Doylestown, PA | $10,000 | 1 |
| , M.D | Gastroenterology | Stanford, CA | $4,311 | 2 |
| , MD | Specialist | Cresskill, NJ | $2,250 | 1 |
| , MD | Medical Oncology | Wyoming, MI | $1,800 | 1 |
| , M.D | Contractor | Bethesda, MD | $1,400 | 1 |
| Andrew Bernstein | Pediatrics | Bel Air, MD | $1,305 | 3 |
| , MD, MPH | Internal Medicine | Poughkeepsie, NY | $808.29 | 3 |
| , MD | Internal Medicine | Charlotte, NC | $600.00 | 1 |
| , M.D | Hospitalist | Greenville, NC | $115.42 | 1 |
| , M.D | Infectious Disease | Greenville, NC | $115.41 | 1 |
| , MD | Infectious Disease | Greenville, NC | $115.41 | 1 |
| , MD | Internal Medicine | New York, NY | $46.83 | 1 |
| Benson Yu | — | Fairfax, VA | $13.62 | 1 |
Ad
Manufacturing Companies
- Dynavax Technologies Corporation $281,507
Product Information
- Type Drug
- Total Payments $281,507
- Total Doctors 14
- Transactions 44
About HEPLISAV-B
HEPLISAV-B is a drug associated with $281,507 in payments to 14 healthcare providers, recorded across 44 transactions in the CMS Open Payments database. The primary manufacturer is Dynavax Technologies Corporation.
Payment data is available from 2018 to 2018. In 2018, $281,507 was paid across 44 transactions to 14 doctors.
The most common payment nature for HEPLISAV-B is "Current or prospective ownership or investment interest" ($156,767, 55.7% of total).